ULLENSVANG VAKSINEKLINIKK AS
Operating
Selge tjenester og varer innen helse, og annet som naturlig
sammenfaller med dette, samt deltakelse i andre selskaper,
investeringer og nærliggende virksomhet.
Organization
- CEO
- MJ
Merethe Jordal1979
- Chairman of the board
- NS
Nina Sandstå1972
- Years since formation
- 5 years
- since Aug 11, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 2
- persons
Financials
- Total operating income 2025
- 391,197
- NOK
- Annual total result 2025
- 19,596
- NOK
- Total equity 2025
- 28,658
- NOK
Last update: Apr 9, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MJ 1979 | Managing Director/CEO | 50 % directly |
Board
| Name | Role | Shares |
|---|---|---|
NS 1972 | Chairman | 50 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MJ 1979 | Managing Director/CEO | 50 % directly |
NS 1972 | Chairman | 50 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
MJ 1979 | Ordinary shares | 15,000 | 50 % |
NS 1972 | Ordinary shares | 15,000 | 50 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total operating income | 391,197 | 338,940 | 217,856 | 187,487 |
Annual Total Result | 19,596 | -44,198 | -47,715 | 41,097 |
Total assets | 51,022 | 41,096 | 58,573 | 41,097 |
Total liabilities | 22,364 | 32,035 | 5,314 | 0 |
Total equity | 28,658 | 9,062 | 53,259 | 41,097 |
P&L
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total operating income | 391,197 | 338,940 | 217,856 | 187,487 |
Total operating costs | 371,764 | 385,379 | 255,204 | 146,390 |
Operating result | 19,433 | -46,439 | -37,348 | 41,097 |
Financial income/costs | 163 | -6,987 | -9,009 | 0 |
Profit before tax | 19,596 | -53,426 | -46,357 | 41,097 |
Total tax & extraordinary income/cost | 0 | -9,228 | 1,358 | 0 |
Annual Total Result | 19,596 | -44,198 | -47,715 | 41,097 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total fixed assets | 14,194 | 21,292 | 28,389 | 0 |
Total current assets | 36,828 | 19,804 | 30,184 | 41,097 |
Total assets | 51,022 | 41,096 | 58,573 | 41,097 |
Short term debt | 21,006 | 30,677 | 3,956 | 0 |
Long term debt | 1,358 | 1,358 | 1,358 | 0 |
Total liabilities | 22,364 | 32,035 | 5,314 | 0 |
Contributed capital | 30,000 | 30,000 | 30,000 | 41,097 |
Retained earnings | -1,342 | -20,938 | 23,259 | 0 |
Total equity | 28,658 | 9,062 | 53,259 | 41,097 |
Total equity and liabilities | 51,022 | 41,097 | 58,573 | 41,097 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises